-
1
page
-
English
-
Documents
Description
HAL Allergy Completes Patient Enrolment for its Phase II Trial with SUBLIVAC® FIX Birch PR Newswire LEIDEN, Netherlands, November 6, 2012 LEIDEN, Netherlands, November 6, 2012 /PRNewswire/ -- HAL Allergy B.V.
-
Publié par
-
Langue
English